Introduction
Peptide purity is one of the most important quality metrics in research peptide procurement and use. When a vendor lists a peptide as 98% or 99% pure, that number carries real implications for research validity and reproducibility. Understanding what peptide purity means, how it is measured, and why it matters helps researchers make informed decisions when sourcing compounds.
What Is Peptide Purity?
Peptide purity refers to the percentage of the product that consists of the intended peptide compound versus other substances. A 98% pure peptide means that 98% of the material in the vial is the target peptide sequence and 2% consists of impurities. These impurities may include truncated peptide sequences, deletion sequences, oxidized variants, residual reagents from synthesis, or other byproducts of the manufacturing process.
How Purity Is Measured
The gold standard for peptide purity analysis is High-Performance Liquid Chromatography (HPLC). In HPLC analysis, the peptide sample is passed through a chromatography column that separates components based on their chemical properties. A detector measures the relative abundance of each component, generating a chromatogram. The purity percentage is calculated from the area of the target peptide peak relative to all peaks in the chromatogram.
Mass spectrometry (MS) is used alongside HPLC to confirm molecular identity — verifying that the primary peak in the chromatogram corresponds to the correct molecular weight for the intended peptide sequence. Together HPLC and MS provide comprehensive quality verification.
Why Purity Matters in Research
Low-purity peptides introduce uncontrolled variables into research. If 5% of a peptide preparation consists of unknown impurities, researchers cannot be certain that observed effects are attributable to the target peptide alone. This is particularly important in dose-response studies where concentration accuracy is critical, and in any research intended for publication or regulatory review.
Common Purity Standards
Research-grade peptides are typically available at purity levels of 95%, 98%, or 99%+. For most preclinical research applications, 98% purity is considered the minimum acceptable standard. Studies requiring high precision or intended to inform further pharmaceutical development may require 99%+ purity with fully documented CoA data.
TFA Removal and Salt Form
An additional purity consideration is the salt form of the peptide. Many peptides are synthesized using trifluoroacetic acid (TFA) during solid-phase synthesis, and residual TFA can remain in the final product. TFA has been shown to affect cell viability in some research models. High-quality vendors offer TFA removal or acetate salt conversion for sensitive research applications.
What to Look for in a Certificate of Analysis
A legitimate CoA should include: the peptide name and sequence, molecular weight, purity percentage from HPLC analysis, mass spec confirmation data, lot number, and testing date. Researchers should request CoAs for every batch purchased and verify that testing was performed on the specific lot being supplied.
Conclusion
Peptide purity is not a marketing claim — it is a measurable, documentable quality metric that directly affects research validity. Sourcing peptides with HPLC-verified purity of 98% or above and confirmed mass spec identity is a basic requirement for any serious preclinical research program.